The journey from idea to IPO is full of twists and turns. Hear how two expert CEOs stayed laser-focused on impact amidst uncertainty, successfully taking their startups public during the COVID pandemic.
This exclusive MassChallenge event featured Thomas Healy, CEO of Hyliion (MC Boston 2015), and Armon Sharei, CEO of SQZ BioTech (MC Boston 2014), and moderated by Misti Cain, the founder at Whyzze.
Speakers shared directly from their combined 20+ years of business and entrepreneurship experience to provide clear takeaways for all founders, whether you are tinkering a new idea or raising your next round. Attendees can expect to gain insight into the key decisions that guided each startup towards IPO, including co-founders, early hires, culture, and investors.
MEET THE SPEAKERS
Armon Sharei, CEO of SQZ Biotech
Dr. Armon Sharei, invented the Cell Squeeze® technology during his PhD in the laboratories of Dr. Klavs Jensen and Dr. Robert Langer at MIT. This innovation overcame major barriers to cell therapy development and implementation. SQZ Biotech was founded with the goal of creating a new generation of cell therapies – cell therapies that could enable transformative patient outcomes across disease areas while remaining safe and practical to administer. Learn more.
Thomas Healy, CEO of Hyliion
Thomas Healy has served as Chief Executive Officer of Hyliion since January 26, 2016. Mr. Healy holds a B.S. degree in Mechanical Engineering with a double-major in Engineering and Public Policy from Carnegie Mellon University. Learn more.
Misti Cain, Founder of Whyzze
Misti Cain is the founder of Whyzze ('wise') - a business strategy company. Whyzze helps leaders and entrepreneurs create step-by-step ‘Profit’, ‘Process’, ‘People’, and ‘Productivity’ business operations plans. Misti is also the host of business reality show Werrrk! by Mailchimp Presents, an all-star mentor for Techstars, and an Executive in Residence for Cal State University San Marcos. Her passion is helping the workforce love Mondays. Learn more.
Stay Connected
Questions?
Reach out directly by emailing: community@masschallenge.org